Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanping Liu

Showing results (601-610 of 622) with videos related to

Pageof 63
Sort By:
Emerging Microbes & Infections|August 1, 2025
Mixed infections and heteroresistance of <i>Mycobacterium tuberculosis</i> among multidrug-resistant tuberculosis in China: a genomic epidemiology studyYanping Liu, Yangyi Zhang, Xiaoyu Lu, et al.
Eclinicalmedicine|February 9, 2026
Safety and immunogenicity of bivalent RSVpreF vaccine formulated in a multidose vial in healthy female participants in the USA: a multicentre, randomised, open-label, noninferiority phase 3 studyUzma N Sarwar, Jeffrey B Baker, Lisa Pereira, et al.
Infectious Diseases and Therapy|June 13, 2024
Cross-Sectional Survey of Factors Contributing to COVID-19 Testing Hesitancy Among US Adults at Risk of Severe Outcomes from COVID-19Annlouise R Assaf, Gurinder S Sidhu, Apurv Soni, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|November 12, 2021
The Preventive Value of Acupoint Sensitization for Patients with Stable Angina Pectoris: A Randomized, Double-Blind, Positive-Controlled, Multicentre TrialShourui Huang, Ling Li, Jiali Liu, et al.
Oral Oncology|February 14, 2025
Mitoxantrone hydrochloride liposome injection for the treatment of Recurrent/Metastatic head and neck squamous cell Carcinoma: A Multicenter, Open-label, Single-arm, phase 1b studyHang Yang, Peng Sun, Yu Wang, et al.
Addiction Science & Clinical Practice|April 21, 2021
Is telemedicine the answer to rural expansion of medication treatment for opioid use disorder? Early experiences in the feasibility study phase of a National Drug Abuse Treatment Clinical Trials Network TrialYih-Ing Hser, Allison J Ober, Alex R Dopp, et al.
Bioorganic Chemistry|December 28, 2024
Discovery of a novel CDK4/6 and HDAC dual-targeting agent for the treatment of hepatocellular carcinomaZizhou Niu, Zhichao Shi, Guoxiang Wu, et al.
Gut|December 21, 2021
Deviated and early unsustainable stunted development of gut microbiota in children with autism spectrum disorderMingxing Lou, Aihua Cao, Cuiyuan Jin, et al.
Annals of Hematology|January 29, 2026
Hemophagocytic lymphohistiocytosis associated with extranodal NK/T cell lymphoma, nasal type or aggressive NK cell leukemia: a retrospective multicenter study of Jiangsu Cooperative Lymphoma Group (JCLG)Yongle Li, Yanping Liu, Yilian Yang, et al.
European Journal of Neurology|January 27, 2026
1-Year Clinical Outcome Post-Myasthenic Crisis: A Multicenter Prospective Study in ChinaXiao Huan, Ran Chen, Lei Jin, et al.
Pageof 63

Showing results (601-610 of 622) with videos related to

Sort By:
Pageof 63
Emerging Microbes & Infections|August 1, 2025
Mixed infections and heteroresistance of <i>Mycobacterium tuberculosis</i> among multidrug-resistant tuberculosis in China: a genomic epidemiology studyYanping Liu, Yangyi Zhang, Xiaoyu Lu, et al.
Eclinicalmedicine|February 9, 2026
Safety and immunogenicity of bivalent RSVpreF vaccine formulated in a multidose vial in healthy female participants in the USA: a multicentre, randomised, open-label, noninferiority phase 3 studyUzma N Sarwar, Jeffrey B Baker, Lisa Pereira, et al.
Infectious Diseases and Therapy|June 13, 2024
Cross-Sectional Survey of Factors Contributing to COVID-19 Testing Hesitancy Among US Adults at Risk of Severe Outcomes from COVID-19Annlouise R Assaf, Gurinder S Sidhu, Apurv Soni, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|November 12, 2021
The Preventive Value of Acupoint Sensitization for Patients with Stable Angina Pectoris: A Randomized, Double-Blind, Positive-Controlled, Multicentre TrialShourui Huang, Ling Li, Jiali Liu, et al.
Oral Oncology|February 14, 2025
Mitoxantrone hydrochloride liposome injection for the treatment of Recurrent/Metastatic head and neck squamous cell Carcinoma: A Multicenter, Open-label, Single-arm, phase 1b studyHang Yang, Peng Sun, Yu Wang, et al.
Addiction Science & Clinical Practice|April 21, 2021
Is telemedicine the answer to rural expansion of medication treatment for opioid use disorder? Early experiences in the feasibility study phase of a National Drug Abuse Treatment Clinical Trials Network TrialYih-Ing Hser, Allison J Ober, Alex R Dopp, et al.
Bioorganic Chemistry|December 28, 2024
Discovery of a novel CDK4/6 and HDAC dual-targeting agent for the treatment of hepatocellular carcinomaZizhou Niu, Zhichao Shi, Guoxiang Wu, et al.
Gut|December 21, 2021
Deviated and early unsustainable stunted development of gut microbiota in children with autism spectrum disorderMingxing Lou, Aihua Cao, Cuiyuan Jin, et al.
Annals of Hematology|January 29, 2026
Hemophagocytic lymphohistiocytosis associated with extranodal NK/T cell lymphoma, nasal type or aggressive NK cell leukemia: a retrospective multicenter study of Jiangsu Cooperative Lymphoma Group (JCLG)Yongle Li, Yanping Liu, Yilian Yang, et al.
European Journal of Neurology|January 27, 2026
1-Year Clinical Outcome Post-Myasthenic Crisis: A Multicenter Prospective Study in ChinaXiao Huan, Ran Chen, Lei Jin, et al.
Pageof 63